{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:12:40Z","timestamp":1793707960323,"version":"4.6.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"The ASAS-perSpA"},{"DOI":"10.13039\/100006483","name":"Abbvie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Janssen and Merck"},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008721","name":"University College London Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We aimed to identify determinants of health-related quality of life (HRQoL) and global functioning and health (GH) in axial SpA (axSpA), peripheral SpA (pSpA) and (PsA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The ASAS-perSpA study data were analysed. Models for the three patient groups were run separately to explore factors associated with HRQoL and GH, assessed by EQ-5D and ASAS-HI, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The analyses included 4185 patients: 2719 with axSpA, 433 with pSpA, and 1033 with PsA.<\/jats:p>\n                  <jats:p>In axSpA, disease activity (\u03b2\u2009=\u2009\u20130.061), physical function (\u03b2\u2009=\u2009\u20130.041), female sex (\u03b2\u2009=\u2009\u20130.019) and fibromyalgia (FM) (\u03b2\u2009=\u2009\u20130.068) were associated with worse HRQoL; age (\u03b2\u2009=\u20090.001) and university education (\u03b2\u2009=\u20090.014) were associated with better HRQoL. In pSpA, disease activity (\u03b2\u2009=\u2009\u20130.04) and physical function (\u03b2\u2009=\u2009\u20130.054) were associated with worse HRQoL. In PsA, disease activity (\u03b2\u2009=\u2009\u20130.045), physical function (\u03b2\u2009=\u2009\u20130.053), axial disease (\u03b2\u2009=\u2009\u20130.041) and female sex (\u03b2\u2009=\u2009\u20130.028) were associated with worse HRQoL. In axSpA, disease activity (\u03b2\u2009=\u20090.889), physical function (\u03b2\u2009=\u20090.887), peripheral disease (\u03b2\u2009=\u20090.564), female sex (\u03b2\u2009=\u20090.812) and FM (\u03b2\u2009=\u20091.639) were associated with worse GH; age (\u03b2\u2009=\u2009\u20130.013) and university education (\u03b2\u2009=\u2009\u20130.274) were associated with better GH. In pSpA, physical function (\u03b2\u2009=\u20091.142) and female sex (\u03b2\u2009=\u20091.060) were associated with worse GH; university education (\u03b2\u2009=\u2009\u20130.611) was associated with better GH. In PsA, disease activity (\u03b2\u2009=\u20090.703), physical function (\u03b2\u2009=\u20091.025), axial involvement (\u03b2\u2009=\u20090.659), female sex (\u03b2\u2009=\u20090.924) and FM (\u03b2\u2009=\u20091.387) were associated with worse GH; age (\u03b2\u2009=\u2009\u20130.024) and university education (\u03b2\u2009=\u2009\u20130.856) were associated with better GH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Disease activity and physical function are major HRQoL and GH determinants across SpA types, and clinical characteristics and sociodemographic factors play an important role, highlighting the importance of a holistic approach for individual patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/kead503","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T20:37:32Z","timestamp":1695415052000},"page":"1938-1948","source":"Crossref","is-referenced-by-count":11,"title":["Determinants of health-related quality of life and global functioning and health in axSpA, pSpA and PsA: results from the ASAS-PerSpA study"],"prefix":"10.1093","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1396-8988","authenticated-orcid":false,"given":"Helena","family":"Santos","sequence":"first","affiliation":[{"name":"Instituto Portugu\u00eas de Reumatologia, Nova Medical School, EpiDoc Unit-CEDOC , Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4581-0843","authenticated-orcid":false,"given":"Ana R","family":"Henriques","sequence":"additional","affiliation":[{"name":"Nova Medical School, EpiDoc Unit\u2014Comprehensive Health Research Center , Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-7972","authenticated-orcid":false,"given":"Pedro M","family":"Machado","sequence":"additional","affiliation":[{"name":"Centre for Rheumatology and Department of Neuromuscular Diseases, University College of London , London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-5837","authenticated-orcid":false,"given":"Clementina","family":"Lopez-Medina","sequence":"additional","affiliation":[{"name":"University Hospital Reina Sofia , C\u00f3rdoba, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-6229","authenticated-orcid":false,"given":"Maxime","family":"Dougados","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Cochin Hospital , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1894-4870","authenticated-orcid":false,"given":"Helena","family":"Canh\u00e3o","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Central, Nova Medical School, EpiDoc Unit-Comprehensive Health Research Center , Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2046-8017","authenticated-orcid":false,"given":"Ana M","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Nova Medical School, EpiDoc Unit-Comprehensive Health Research Center, Rheumatology Department Hospital dos Lus\u00edadas, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2816-7705","authenticated-orcid":false,"given":"Fernando","family":"Pimentel-Santos","sequence":"additional","affiliation":[{"name":"NOVA Medical Research (NMR) \u2013 iNOVA4 Health, Rheumatic Diseases Lab\u2014Nova Medical School , Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"2024070114083442800_kead503-B1","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/S0140-6736(18)31946-9","article-title":"Spondyloarthritis","volume":"392","author":"van der Heijde","year":"2018","journal-title":"Lancet"},{"key":"2024070114083442800_kead503-B2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2024070114083442800_kead503-B3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024070114083442800_kead503-B4","doi-asserted-by":"crossref","first-page":"e001450","DOI":"10.1136\/rmdopen-2020-001450","article-title":"Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study","volume":"7","author":"L\u00f3pez-Medina","year":"2021","journal-title":"RMD Open"},{"key":"2024070114083442800_kead503-B5","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0277-9536(95)00112-K","article-title":"The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization","volume":"41","author":"The WHOQOL Group\u2217","year":"1995","journal-title":"Soc Sci Med"},{"key":"2024070114083442800_kead503-B6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/annrheumdis-2019-216143","article-title":"Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS)","volume":"79","author":"Macfarlane","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2024070114083442800_kead503-B7","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s11136-016-1345-z","article-title":"The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysis","volume":"25","author":"Yang","year":"2016","journal-title":"Qual Life Res"},{"key":"2024070114083442800_kead503-B8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40744-019-0160-8","article-title":"Insight into the quality of life of patients with ankylosing spondylitis: real-world data from a US-based life impact survey","volume":"6","author":"Rosenbaum","year":"2019","journal-title":"Rheumatol Ther"},{"key":"2024070114083442800_kead503-B9","first-page":"ii14","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64(Suppl 2)","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2024070114083442800_kead503-B10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1529-0131(200104)45:2<151::AID-ANR168>3.0.CO;2-T","article-title":"Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis","volume":"45","author":"Husted","year":"2001","journal-title":"Arthritis Care Res"},{"key":"2024070114083442800_kead503-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-7-25","article-title":"The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people","volume":"7","author":"Salaffi","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"2024070114083442800_kead503-B12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2017-212076","article-title":"Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis","volume":"77","author":"Kiltz","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2024070114083442800_kead503-B13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/annrheumdis-2013-203967","article-title":"Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS","volume":"74","author":"Kiltz","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024070114083442800_kead503-B14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11136-013-0488-4","article-title":"EQ-5D Portuguese population norms","volume":"23","author":"Ferreira","year":"2014","journal-title":"Qual Life Res"},{"key":"2024070114083442800_kead503-B15","doi-asserted-by":"crossref","first-page":"151996","DOI":"10.1016\/j.semarthrit.2022.151996","article-title":"Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials","volume":"54","author":"Ho","year":"2022","journal-title":"Semin. Arthritis Rheum"},{"key":"2024070114083442800_kead503-B16","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/rheumatology\/keu438","article-title":"Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab","volume":"54","author":"Van Der Heijde","year":"2015","journal-title":"Rheumatology"},{"key":"2024070114083442800_kead503-B17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3899\/jrheum.170796","article-title":"In early axial spondyloarthritis, increasing disease activity is associated with worsening of health-related quality of life over time","volume":"45","author":"Van Lunteren","year":"2018","journal-title":"J. Rheumatology"},{"key":"2024070114083442800_kead503-B18","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s10067-018-4112-4","article-title":"Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage","volume":"37","author":"L\u00f3pez-Medina","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2024070114083442800_kead503-B19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/acr.22908","article-title":"Disease activity as a major determinant of quality of life and physical function in patients with early axial spondyloarthritis","volume":"69","author":"Fern\u00e1ndez-Carballido","year":"2017","journal-title":"Arthritis Care Res"},{"key":"2024070114083442800_kead503-B20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.vhri.2021.06.003","article-title":"Health-related quality of life in psoriatic arthritis: findings and implications","volume":"26","author":"Moraes","year":"2021","journal-title":"Value Heal Reg Issues"},{"key":"2024070114083442800_kead503-B21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12955-019-1260-4","article-title":"Relationship between disease activity status or clinical response and patient-reported outcomes in patients with non-radiographic axial spondyloarthritis: 104-week results from the randomized controlled EMBARK study","volume":"18","author":"Dougados","year":"2020","journal-title":"Health Qual Life Outcomes"},{"key":"2024070114083442800_kead503-B22","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.39008","article-title":"Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis","volume":"67","author":"Mease","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2024070114083442800_kead503-B23","first-page":"1285","article-title":"Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study","volume":"40","author":"Navarini","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2024070114083442800_kead503-B24","first-page":"e27359","article-title":"Burden and disease characteristics of psoriatic arthritis at a tertiary center","volume":"14","author":"Attar","year":"2022","journal-title":"Cureus"},{"key":"2024070114083442800_kead503-B25","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/ard.2011.150037","article-title":"A stratified model for health outcomes in ankylosing spondylitis","volume":"70","author":"Machado","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2024070114083442800_kead503-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-018-1784-8","article-title":"Factors related to health-related quality of life in ankylosing spondylitis, overall and stratified by sex","volume":"20","author":"Law","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2024070114083442800_kead503-B27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3899\/jrheum.160411","article-title":"Five potentially modifiable factors predict poor quality of life in ankylosing spondylitis: results from the Scotland registry for ankylosing spondylitis","volume":"45","author":"Dean","year":"2018","journal-title":"J Rheumatol"},{"key":"2024070114083442800_kead503-B28","doi-asserted-by":"crossref","first-page":"152086","DOI":"10.1016\/j.semarthrit.2022.152086","article-title":"Determinants of health-related quality of life in spondyloarthritis and rheumatoid arthritis - data from the COMOSPA and COMORA studies","volume":"57","author":"Carvalho","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"2024070114083442800_kead503-B29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40744-016-0029-z","article-title":"Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey","volume":"3","author":"Kavanaugh","year":"2016","journal-title":"Rheumatol Ther"},{"key":"2024070114083442800_kead503-B30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/rmdopen-2020-001223","article-title":"Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: a cross-sectional study of outpatient clinic patients in the biologic treatment era","volume":"6","author":"Haugeberg","year":"2020","journal-title":"RMD Open"},{"key":"2024070114083442800_kead503-B31","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3899\/jrheum.121500","article-title":"Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis","volume":"40","author":"Husted","year":"2013","journal-title":"J Rheumatol"},{"key":"2024070114083442800_kead503-B32","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3899\/jrheum.210349","article-title":"Does age matter in psoriatic arthritis? A narrative review","volume":"49","author":"Fragoulis","year":"2022","journal-title":"J Rheumatol"},{"key":"2024070114083442800_kead503-B33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/pm\/pny062","article-title":"Pain intensity, disability, and quality of life in patients with chronic low back pain: does age matter?","volume":"20","author":"Wettstein","year":"2019","journal-title":"Pain Med"},{"key":"2024070114083442800_kead503-B34","doi-asserted-by":"crossref","first-page":"iv38","DOI":"10.1093\/rheumatology\/keaa543","article-title":"Sex and gender differences in axial spondyloarthritis: myths and truths","volume":"59","author":"Rusman","year":"2020","journal-title":"Rheumatology"},{"key":"2024070114083442800_kead503-B35","first-page":"419","article-title":"Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the outcome in ankylosing spondylitis international study","volume":"55","author":"Webers","year":"2016","journal-title":"Rheumatology"},{"key":"2024070114083442800_kead503-B36","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12891-017-1693-z","article-title":"The relationship between demographic- and disease-related variables and health-related quality of life in patients with axial spondyloarthritis","volume":"18","author":"Rohde","year":"2017","journal-title":"BMC Musculoskelet Disord"},{"key":"2024070114083442800_kead503-B37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13075-020-02337-2","article-title":"Differences between men and women with nonradiographic axial spondyloarthritis: clinical characteristics and treatment effectiveness in a real-life prospective cohort","volume":"22","author":"Neuenschwander","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2024070114083442800_kead503-B38","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/rheumatology\/keaa353","article-title":"Determinants of the patient global assessment of well-being in early axial spondyloarthritis: 5-year longitudinal data from the DESIR cohort","volume":"60","author":"Hirano","year":"2021","journal-title":"Rheumatology"},{"key":"2024070114083442800_kead503-B39","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3899\/jrheum.171094","article-title":"Influence of axial involvement on clinical characteristics of psoriatic arthritis: analysis from the corrona psoriatic arthritis\/spondyloarthritis registry","volume":"45","author":"Mease","year":"2018","journal-title":"J Rheumatol"},{"key":"2024070114083442800_kead503-B40","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3899\/jrheum.171406","article-title":"Influence of disease manifestations on health-related quality of life in early psoriatic arthritis","volume":"45","author":"Wervers","year":"2018","journal-title":"J Rheumatol"},{"key":"2024070114083442800_kead503-B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.berh.2019.06.005","article-title":"The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis","volume":"33","author":"Zhao","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2024070114083442800_kead503-B42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/1756-185X.13987","article-title":"Fibromyalgia in patients with psoriatic arthritis: impact on disease activity indices, fatigue and health-related quality of life","volume":"24","author":"Elsawy","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2024070114083442800_kead503-B43","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/jcm8040467","article-title":"Predictors of Assessment of Spondyloarthritis International Society (ASAS) Health Index in Axial Spondyloarthritis and Comparison of ASAS Health Index between Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: data from the Catholic Axial","volume":"8","author":"Min","year":"2019","journal-title":"J Clin Med"},{"key":"2024070114083442800_kead503-B44","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3899\/jrheum.200025","article-title":"Performance of the ASAS health index for the evaluation of spondyloarthritis in daily practice","volume":"47","author":"Alonso","year":"2020","journal-title":"J Rheumatol"},{"key":"2024070114083442800_kead503-B45","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/rheumatology\/keaa626","article-title":"Construct validity of the ASAS health index in psoriatic arthritis: a cross-sectional analysis","volume":"60","author":"Morante","year":"2021","journal-title":"Rheumatology"},{"key":"2024070114083442800_kead503-B46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/art.11197","article-title":"Physical function and health-related quality of life of Spanish patients with ankylosing spondylitis","volume":"49","author":"Ariza-Ariza","year":"2003","journal-title":"Arthritis Care Res"},{"key":"2024070114083442800_kead503-B47","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3899\/jrheum.081015","article-title":"Spondyloarthritis is associated with poor function and physical health-related quality of life","volume":"36","author":"Singh","year":"2009","journal-title":"J Rheumatol"},{"key":"2024070114083442800_kead503-B48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.55563\/clinexprheumatol\/zr61xv","article-title":"ASAS Health Index in patients with spondyloarthritis and its association with disease activity and disease burden including fibromyalgia","volume":"39(Suppl 130)","author":"Puche Larrubia","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"2024070114083442800_kead503-B49","doi-asserted-by":"crossref","first-page":"e0235678","DOI":"10.1371\/journal.pone.0235678","article-title":"Gender difference in ASAS HI among patients with ankylosing spondylitis","volume":"15","author":"Chen","year":"2020","journal-title":"PLoS One"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/kead503\/52044643\/kead503.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/7\/1938\/58378101\/kead503.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/63\/7\/1938\/58378101\/kead503.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T17:59:14Z","timestamp":1719856754000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/63\/7\/1938\/7280160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,9,21]]},"published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kead503","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2023,9,21]]}}}